Bill & Melinda Gates Foundation - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 167 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bill & Melinda Gates Foundation ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$13,876,364
-12.1%
1,559,1420.0%23.22%
+23.7%
Q1 2024$15,794,108
+0.7%
1,559,1420.0%18.77%
+7.6%
Q4 2023$15,684,969
+7.4%
1,559,1420.0%17.45%
+0.2%
Q3 2023$14,609,161
-61.8%
1,559,1420.0%17.42%
-42.8%
Q2 2023$38,245,753
+5.4%
1,559,1420.0%30.44%
-5.0%
Q1 2023$36,281,234
-8.1%
1,559,1420.0%32.04%
+5.4%
Q4 2022$39,461,884
+31.1%
1,559,1420.0%30.41%
+27.8%
Q3 2022$30,100,000
-24.2%
1,559,1420.0%23.79%
-22.0%
Q2 2022$39,700,000
-1.0%
1,559,1420.0%30.52%
+41.5%
Q1 2022$40,100,000
+41.2%
1,559,142
+130.0%
21.56%
+150.2%
Q4 2021$28,400,000
-3.7%
677,7770.0%8.62%
-0.2%
Q3 2021$29,500,000
-77.5%
677,777
-75.6%
8.64%
-57.1%
Q2 2021$131,000,000
-8.0%
2,777,7770.0%20.13%
-13.6%
Q1 2021$142,417,000
+92.5%
2,777,7770.0%23.30%
+37.9%
Q4 2020$74,000,0002,777,77716.90%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,700,00030.52%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$565,858,0004.50%
Zebra Capital Management LLC 25,419$647,0001.90%
Alaska Permanent Fund Corp 2,300,000$58,581,0000.84%
CLARK ESTATES INC/NY 180,000$4,585,0000.79%
Temasek Holdings (Private) Ltd 5,602,553$142,697,0250.78%
SECTOR GAMMA AS 110,223$2,807,0000.63%
Avidity Partners Management LP 758,211$19,312,0000.44%
New Vernon Capital Holdings II LLC 14,501$369,0000.30%
DUALITY ADVISERS, LP 116,415$2,965,0000.29%
View complete list of VIR BIOTECHNOLOGY INC shareholders